Granules India: Q1 FY26 Earnings Call Scheduled For August 12 At 4 PM 📅📞

 21 Jul 2025 11:27 AM

Granules India: Q1 FY26 Earnings Call Scheduled For August 12 At 4 PM 📅📞

Granules India recalls 33,000 bottles of blood lowering medication in US

 09 Jul 2025 02:53 PM

Granules India is recalling over 33,000 bottles of Metoprolol Succinate, a generic blood pressure medication, in the US due to manufacturing issues. The USFDA reported that the India-produced lot failed to meet dissolution specifications during stability studies. This Class II recall, initiated on June 24, indicates a potential for temporary or medically reversible health consequences.

Granules India: Company's Unit Successfully Finishes US FDA Pre-Approval Inspection With One 483 Observation Resolved. 🏭✅

 28 Jun 2025 03:59 PM

Granules India: Company's Unit Successfully Finishes US FDA Pre-Approval Inspection With One 483 Observation Resolved. 🏭✅

Granules India shares in focus after US FDA flags observation at Telangana API facility

 23 Jun 2025 09:13 AM

The US FDA issued a Form 483 observation for its Telangana API facility. While not a final non-compliance verdict, the company plans a timely response. The facility is key for paracetamol API production. The stock has fallen 19% YTD but remains a ‘Strong Buy’.

Granules India: Co Successfully Finishes USFDA Inspection At Its API Unit-I Facility In Bonthapally, Telangana, Resulting In One Form 483 Observation. 🏭✅

 20 Jun 2025 04:36 PM

Granules India: Co Successfully Finishes USFDA Inspection At Its API Unit-I Facility In Bonthapally, Telangana, Resulting In One Form 483 Observation. 🏭✅

GRANULES INDIA: CO FY25 EBITDA MARGIN AT 21%, IN-LINE WITH GUIDANCE OF 20-22%

 28 May 2025 01:55 PM

GRANULES INDIA: CO FY25 EBITDA MARGIN AT 21%, IN-LINE WITH GUIDANCE OF 20-22%

GRANULES INDIA: CO SAYS THAT REVENUE SHARE FROM NORTH AMERICA INCREASED TO 79% IN Q4FY25 VS 70% IN Q4FY24

 28 May 2025 01:54 PM

GRANULES INDIA: CO SAYS THAT REVENUE SHARE FROM NORTH AMERICA INCREASED TO 79% IN Q4FY25 VS 70% IN Q4FY24

GRANULES INDIA: Q4 EBITDA 2.52B RUPEES VS 2.56B (YOY) || Q4 EBITDA MARGIN 21.07% VS 21.75% (YOY)

 28 May 2025 01:24 PM

GRANULES INDIA: Q4 EBITDA 2.52B RUPEES VS 2.56B (YOY) || Q4 EBITDA MARGIN 21.07% VS 21.75% (YOY)

GRANULES INDIA: CO DECLARES DIVIDEND OF RUPEES 1.5 PER SHARE

 28 May 2025 01:24 PM

GRANULES INDIA: CO DECLARES DIVIDEND OF RUPEES 1.5 PER SHARE

GRANULES INDIA: Q4 REVENUE 12B RUPEES VS 11.8B (YOY)

 28 May 2025 01:23 PM

GRANULES INDIA: Q4 REVENUE 12B RUPEES VS 11.8B (YOY)